JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nasim, M. T.
Right arrow Articles by McCarthy, J. E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nasim, M. T.
Right arrow Articles by McCarthy, J. E. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 20, 14846-14852, May 19, 2000


Eukaryotic Selenocysteine Incorporation Follows a Nonprocessive Mechanism That Competes with Translational Termination*

Muhammad Talat NasimDagger §, Susanne JaeneckeDagger §, Ali BelduzDagger , Heike KollmusDagger , Leopold Flohé, and John E. G. McCarthyDagger ||

From the Dagger  Posttranscriptional Control Group, Department of Biomolecular Sciences, University of Manchester Institute of Science and Technology, Manchester M60 1QD, United Kingdom and  Department of Biochemistry, Technische Universität Braunschweig, Mascheroder Weg 1, D-38124 Braunschweig, Germany

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The synthesis of eukaryotic selenoproteins involves the recoding of an internal UGA codon as a site for selenocysteine incorporation. This recoding event is directed by a selenocysteine insertion sequence in the 3'-untranslated region. Because UGA also functions as a signal for peptidyl-tRNA hydrolysis, we have investigated how the rates of translational termination and selenocysteine incorporation relate to cis-acting elements in the mRNA as well as to trans-acting factors in the cytoplasm. We used cis-elements from the phospholipid glutathione peroxidase gene as the basis for this work because of its relatively high efficiency of selenocysteine incorporation. The last two codons preceding the UGA were found to exert a far greater influence on selenocysteine incorporation than nucleotides downstream of it. The efficiency of selenocysteine incorporation was generally much less than 100% but could be partially enhanced by concomitant overexpression of the tRNASec gene. The combination of two or three UGA codons in one reading frame led to a dramatic reduction in the yield of full-length protein. It is therefore unlikely that multiple incorporations of selenocysteine are processive with respect to the mode of action of the ribosomal complex binding to the UGA site. These observations are discussed in terms of the mechanism of selenoprotein synthesis and its ability to compete with termination at UGA codons.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Selenocysteine, the twenty-first amino acid (1, 2), is cotranslationally incorporated into a number of prokaryotic and eukaryotic proteins (3, 4). Although many of the basic mechanistic principles underlying this process in bacteria have been elucidated, the incorporation pathway in eukaryotic cells remains unknown. In all systems studied so far, the opal nonsense codon UGA is given an alternative coding status that allows it to encode selenocysteine. In Escherichia coli, this recoding depends on the presence of a stem-loop structure bearing specific sequences immediately 3' of the UGA (5). Unlike its prokaryotic counterpart, the eukaryotic element is located in the 3'-untranslated region (3'-UTR; Ref. 6),1 and is capable of acting at distances greater than 5000 nucleotides (7, 8). This element has been called the selenocysteine insertion sequence (SECIS). The highly conserved sequences in the SECIS element are: AAA in or near the apical loop, GA on the 3' side of the stem, and AUGA on the 5' side of the stem. A particular focus of attention has recently been the sequence region including the GA and AUGA elements, which is thought to form a non-Watson-Crick base paired duplex structure (9, 10).

The recoding of UGA depends on a number of specific trans-acting components. In bacteria, a special type of seryl-tRNA (tRNASec; SelC) decodes the opal codon as selenocysteine with the assistance of a dedicated EF-Tu-like factor called SelB (1, 2, 11, 12). The synthesis of selenocysteyl-tRNASec from seryl-tRNASec requires three further proteins (SelA, SelC, and SelD; Refs. 13-15). The greatest stumbling block to elucidating the mechanism of selenocysteine incorporation in eukaryotes has been uncertainty as to the nature of the eukaryotic equivalent(s) to SelB. There have been reports of at least four different SECIS-binding proteins (16-20). So far, a 120-kDa protein seems to be the most likely candidate for binding specifically to SECIS elements (20), but further work will be needed to determine the other binding partners of this factor and its role in the selenocysteine incorporation process. Most importantly, there is evidence that the 120-kDa protein forms a complex with other proteins, which may mean that the identified SECIS-binding factor is only part of a multicomponent machinery. One potential component of such a complex could be the selenocysteyl-tRNASec-protecting factor described by Yamada and colleagues (21).

An important unresolved question is to what extent the synthesis of polypeptide chains beyond an internal UGA codon by virtue of selenocysteine incorporation may be substoichiometric. This would explain why the substitution of a cysteine codon (UGU or UGC) at the site of a UGA results in greatly enhanced levels of polypeptide synthesis (22-24). At the same time, it is essential to consider the implications of UGA recoding for the termination process on the ribosome. It has been suggested that unless the distance between the UGA and the SECIS element is suboptimal, termination will be suppressed (3). However, there has been no systematic study to date of the relationship between translation termination and selenocysteine incorporation. In the present work we examine the properties of the UGA site that can influence both the efficiency with which selenocysteine is incorporated and the rate of polypeptide chain termination. There is a further aspect of selenoprotein synthesis that has previously remained unexplained. Genes such as those encoding selenoprotein P (25) and human type 2 iodothyronine deiodinase (8) contain multiple UGA codons. This raises the question as to how selenocysteine can be repeatedly inserted at up to 10 positions within the same polypeptide. In the following work, we examine whether processivity is likely to be the molecular basis for this phenomenon.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plasmid Constructs-- All DNA manipulations were performed according to standard protocols (26). Synthetic oligonucleotides used in plasmid constructions are listed in Table I. To construct the master plasmids pH8A and pH9A, the oligonucleotide pair (PHGPXL-A and PHGPXSL-B) containing the in-frame TGA codon of the phospholipid hydroperoxide glutathione peroxidase gene (nucleotides 165-255) of S. scrofa (GenBankTM accession number X76009) was subcloned between the BamHI and SalI sites of the plasmids pBLUGA and pBPHGPx3U (23). PBPHGPx3U contains the PHGPx SECIS element in its 3'-UTR. To mutate the TGA codon to TGC, PCR was carried out using the primers PHGP-Xho and PHGP-Bam, and the resulting PCR fragment was inserted between the SalI and BamHI sites of the plasmids pBLUGA and pBPHGPx3U. The resulting plasmids were designated pH8B and pH9B. To mutate the fourth base G to A, C, and T, several PCRs were carried out using the forward primers PHGP-A, PHGP-C, and PHGP-T combined with PHGP-Bam as a reverse primer, respectively. The resulting PCR fragments were inserted between the SalI and BamHI sites of the plasmids pBPLUGA and pBPHGPx3U. The resulting plasmids were designated pT11-pT16. The nature of the fourth base and the presence or absence of the PHGPx SECIS element are indicated in Table II.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Oligodeoxyribonucleotides used in this work
TGA codons, TGC codons, and +4 positions are underlined. The complementary oligonucleotide pairs are designated A and B, respectively.

                              
View this table:
[in this window]
[in a new window]
 
Table II
The plasmid constructs
The table indicates whether cysteine (O) or selenocysteine (I) is encoded, changes in the +4 position (underlined), changes in codons -2 and -1 (DR), mutations in the downstream stem-loop structure (SL), and the presence (+) or absence (-) of the SECIS element.

To mutate the penultimate codons positioned at -1 and -2 relative to the TGA codon, the oligonucleotide pair (PHGPXL-A and PHGPXL-B) was digested with SalI and then subcloned between the BamHI and SalI sites of the plasmid pBPHGPx3U, generating pT5. An oligonucleotide pair (PHGP-1-2 A/B) harboring a region of the PHGPx gene (the amino acids serine and glutamine at positions 44 and 45 were changed to aspartic acid and arginine, respectively) was subcloned in the SalI site of the plasmid pT5. To destabilize the predicted stem-loop located downstream of the TGA codon, an oligonucleotide pair (PHGP-LOA and PHGP-LOB) containing mutations in the stem-loop was subcloned into the SalI site of the plasmid pT5.

To investigate selenocysteine incorporation at multiple sites, additional in-frame TGA codons were inserted in the lacZ::luc reporter system. The oligonucleotide pairs SelP1X-A/B, SelP2X-A/B, SelP12X-A/B, and SelP12C-A/B containing the selenoprotein P gene of H. sapiens (GenBankTM accession number Z11793, amino acids 300-318; the in-frame TGA codons are located at positions 300 and 318) were subcloned in the BamHI site of the plasmids pH8A, pH8B, pH9A, and pH9B. The oligonucleotide pairs contain TGA and TGC codons in various combinations so that the constructs contain one, two, or three TGA (or TGC) codons. The resulting plasmids were designated pT18-pT33. The plasmids are listed in Table II.

Xenopus tRNASec (the SelC equivalent) and the SelD gene (SelD4-CDM8) were provided by Dr. Alain Krol (27) and Dr. Marla Berry (28), respectively. The Xenopus release factor genes were supplied already cloned in the expression plasmids pCYM1-11/XSUP35 (29) and pXLCL1 (30) by Prof. Michel Philippe (CNRS, Rennes, France).

Cell Culture, Gene Transfer, and Enzyme Assays-- BHK-21 cells (baby hamster kidney cells; ATCC CC110) were cultivated as described elsewhere (24). Transient transfections were performed using Superfect transfection reagent (Qiagen) following the manufacturer's protocol. beta -Galactosidase and luciferase activities were measured according to the protocol described previously (24). Selenium supplementation, where used, was achieved by adding Na2Se2O3 to give a final concentration of 5 µg l-1.

RNA Isolation and Reverse Transcriptase-PCR-- Isolation of total RNA and reverse transcriptase-PCR were performed using TRIzol® reagent and SuperscriptTM (Life Technologies), respectively, following the manufacturer's protocols. PCR was performed using primers against the lacZ::luc mRNA and against actin mRNA (as a reference) for 22, 26, 32, and 36 cycles.

SDS-Polyacrylamide Gel Electrophoresis and Western Blotting-- SDS-polyacrylamide gel electrophoresis was carried out according to the protocol described by Laemmli (31). Western blotting was performed using a semi-dry method (32) using cell extracts prepared according to an earlier protocoll (24).

Determination of Selenocysteine Incorporation and Translation Termination-- The reporter system used in this work is based on the genes encoding beta -galactosidase and luciferase, which are fused in-frame via a selenoprotein gene sequence including TGA stop codon(s) (24). Upon transfection of the respective plasmids into BHK-21 cell lines, the DNA is transcribed under control of the SV40 promoter, and translation leads to the synthesis of reporter enzymes. Translation terminates at the internal in-frame UGA stop codon, which leads to the synthesis of beta -galactosidase enzyme. The presence of a SECIS element in the 3'-UTR suppresses the UGA stop codon by directing recoding for selenocysteine, which leads to the production of the beta -galactosidase-luciferase fusion protein. Calculation of either termination or suppression efficiency is based on the parallel transfection of a plasmid which contains TGC (cysteine) instead of TGA. The ratio of enzymatic activities of the cells transfected with this plasmid was taken as the reference value (set at 100%). In the investigation of the influence of the +4 position on selenocysteine incorporation, the value obtained with G was taken as the 100% reference value.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Environment of the UGA-- The first stage of our investigation of the factors influencing selenocysteine incorporation efficiency in mammalian selenoproteins focused on the role of the immediate environment of the UGA site. It was our intention to obtain information about the possible upper limits of incorporation efficiency. We therefore chose the pig heart phospholipid hydroperoxide glutathione peroxidase (PHGPx; Ref. 33) gene as a starting point, because previous work had shown that the SECIS of this gene supported a higher incorporation efficiency than the other SECIS elements tested (24). We used a fusion reporter system (Ref. 24 and Fig. 1) to study the influence of the UGA environment. In using this system, we compare the suppression of termination at the central UGA in the presence and in the absence of the SECIS element. In this way, we can determine the recoding that is strictly related to a SECIS-dependent pathway, which reflects selenocysteine incorporation. The reporter gene system is expressed from the SV40 promoter in vivo after transfection of mammalian cells. Translation can either terminate at the C terminus of lacZ or, upon suppression of the nonsense function of the UGA codon, continue through the linker sequence to generate a fusion protein of beta -galactosidase and luciferase (Fig. 1). Because we found that supplementation of the culture medium with Na2SeO3 had no effect on the results obtained with this reporter system (data not shown), all the experiments described in this paper were performed in the absence of a selenium supplement.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   The reporter system used in this work. This was based on the master construct described previously (24). The lacZ and Luc reading frames are joined by a spacer region that in the current work comprises segments of naturally occurring selenoprotein genes, as indicated in the later figures in this paper. In the absence of a SECIS element, termination at a UGA within the spacer yields a C-terminally extended version of beta -galactosidase. Suppression of the UGA mediated by a SECIS element leads to synthesis of a beta -gal::Luc fusion protein with both enzyme activities.

We examined whether the activity of the PHGPx UGA, like its counterpart in the type 1 deiodinase gene (34), is sensitive to the downstream context. The results confirmed that SECIS-dependent incorporation is increased when the fourth base is a pyrimidine (Fig. 2B). This effect is therefore common to different UGA contexts and SECIS elements. We wished to compare this result with the effects of changes in other features of the UGA context that have not previously been investigated. The first of these is the potential influence of mRNA structure downstream of the UGA. For example, a predicted stem-loop structure could potentially be formed 9 nucleotides downstream of the UGA in the PHGPx gene (Fig. 2C). It is known that downstream structure plays a key role in the selenocysteine incorporation process in E. coli (5). Could it also at least modulate the efficiency of eukaryotic selenocysteine incorporation, perhaps by virtue of its ability to cause ribosomes to pause longer at the UGA? We investigated whether mutating the putative stem-loop to destabilize it would affect selenocysteine incorporation (Fig. 2C). Any effect is evidently marginal, thus indicating that downstream secondary structure is unlikely to be involved in eukaryotic selenocysteine incorporation. We conclude that the nature of the nucleotide at the +4 position relative to the UGA is likely to be the most relevant feature of the downstream region in terms of determination of the rate of selenocysteine incorporation.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   The influence of position +4 relative to the UGA codon on selenocysteine incorporation. A, a segment of the porcine PHGPx gene (GenBankTM accession number X76009) containing nucleotides 165-255 was used as the site of selenocysteine incorporation between lacZ and Luc (compare Fig. 1). The TGA codon is overlined. The arrows indicate nucleotides that could form a putative stem-loop structure (see panel C). B, the above region was inserted between the BamHI and SalI sites of plasmids pBLUGA and pBPHGPx3' U (Ref. 24, Fig. 1, and Table I). The fourth base was varied as shown. The TGA codon was also changed to TGC to generate cysteine-encoding controls. The efficiency of SECIS-dependent stop codon suppression was determined by measuring the activities of luciferase and beta -galactosidase in transient transfection experiments of BHK-21 cells using plasmids without and with the PHGPx SECIS element. The luciferase activity was normalized to the activity of beta -galactosidase using as a reference the efficiency obtained with cells that contained a TGC control construct. Each SECIS-dependent relative efficiency was then corrected by subtracting the corresponding SECIS-independent stop codon suppression efficiency. The values given here are expressed as percentages of the value obtained with the plasmid containing a guanine nucleotide in the +4 base position. The relative efficiencies represent mean values (± standard deviations), each of which was obtained from at least six different transfection experiments. All transfection experiments were carried out in duplicate. C, the effect of predicted downstream secondary structure on selenocysteine incorporation. To destabilize the putative downstream stem-loop, the nucleotides G, A, and C were changed to A, U, and U, respectively. The relative values obtained for the wild type (WL) and modified (SL) versions of the putative stem-loop structures are indicated.

In stark contrast to this latter result, we found that changes in the codons immediately upstream of the UGA can markedly affect selenocysteine incorporation efficiency (Fig. 3). We replaced the penultimate and final amino acid encoding triplets preceding the UGA in PHGPx with two codons that belong to a group of termination-promoting codons (Fig. 3A and Ref. 35). The impact on selenocysteine incorporation was dramatic. We also observed that the combination of amino acids substituted in these experiments is avoided in all of the known UGA gene contexts found in selenoprotein genes (Fig. 3B). We conclude from this result that the selenocysteine incorporation rate of the PHGPx UGA is not normally restricted by the presence of 5' neighbor codons that promote strong termination. Indeed, overall we were not able to identify any cis-acting elements within the open reading frame that could markedly improve selenocysteine incorporation efficiency at the PHGPx UGA.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   A, the amino acids at positions -2 and -1 were changed to aspartic acid and arginine, respectively. The effect of mutations (DR) in the penultimate and final codons on selenocysteine incorporation in transient transfection experiments is evident in the comparative Luc/beta -gal values shown next to the diagram (wild type set to 100%). B, analysis of the amino acid context of selenoprotein genes. The amino acids aspartic acid and arginine, which promote efficient termination, are not encoded at the -2 and -1 positions of any known selenoprotein genes. U43285, mouse selenophosphate synthetase 2; L417321, Rana catesbeiana 5' deiodinase type III; U11762, Canis familiaris type I iodothyronine deiodinase; AF093774, human type 2 iodothyronine deiodinase; U67890, mouse selenoprotein W; X13709, human glutathione peroxidase; X76009, pig phospholipid hydroperoxide glutathione peroxidase; X99807, mouse selenoprotein P.

Modulation by Trans-acting Factors-- We investigated whether the use of a reporter system introduced by transient transfection might lead to partial saturation of the selenocysteine incorporation machinery, thus potentially restricting the maximum attainable efficiency of selenocysteine incorporation. The results of earlier studies were not conclusive. One group found that co-transfection of tRNASec (SelC) enhances selenocysteine incorporation in transiently transfected human embryonic kidney cells (23), whereas another group observed no increase in the synthesis of selenoproteins as a consequence of tRNASec overexpression in Chinese hamster ovary cells (36). To address this question in our reporter system, we examined whether the co-transfection of a SelC expression construct would affect the incorporation efficiencies. We found that the incorporation efficiency at UGAG or UGAC was increased by up to approximately 2-fold (Fig. 4). In further experiments, we co-transfected both SelC and SelD. The addition of the latter gene did not enhance the incorporation efficiency any further. In fact, the co-transfection of both SelC and SelD yielded a somewhat smaller enhancement in the incorporation efficiency. Overall, therefore, some increase in selenocysteine incorporation efficiency was supported by an enlargement in the size of the cellular tRNASec pool.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4.   Co-transfection of selC and selD genes. Transient co-transfections of BHK-21 cells were performed using the relevant plasmids (pH8B, pH8A, pH9A, pT12, and pT15) along with plasmids bearing selC and selD genes. Stop codon suppression efficiencies were estimated relative to the values obtained in control (Cont.) cells lacking co-transfected plasmids. Reporter constructs were used containing either UGAC (A) or UGAG (B) as selenocysteine incorporation site. Co-transfection experiments were performed using expression constructs encoding eRF1, eRF3, or both eRF1 and eRF3 (C). The lacZ::luc reporter constructs used had either no SECIS element in the 3'-UTR (pBPLUGA), only the PHGPx SECIS element (pBPPHGPx), the entire PHGPx 3'-UTR (pBPHGPx3U), or the rat 5'-deiodinase SECIS (pBDI).

There is some ambiguity about the dual role of internal UGA codons in selenoprotein genes, in that estimates of the efficiency of selenocysteine incorporation have varied from a few percent of the polypeptide chains reaching the UGA being extended (23) to the suggestion that this process fully suppresses termination (3). Generally, the absolute efficiencies of selenocysteine incorporation in the known selenoproteins remain unknown quantities. Clearly, if termination and selenocysteine incorporation can both take place at the same UGA, these two processes may effectively proceed competitively. One possible way of testing this model is to examine whether increasing the levels of the translation release factors leads to suppression of selenocysteine incorporation. To perform this experiment, we co-transfected individual reporter constructs together with expression constructs bearing the genes encoding eRF1 and eRF3 (29, 30). Comparison with the control construct pBLUGA revealed that there was little specific repression of selenocysteine incorporation associated with the overproduction of the eRFs (Fig. 4C).

Permutations of Multiple UGA Codons-- Further insight into the mechanism of selenocysteine incorporation can be obtained by studying how the system deals with open reading frames containing more than one UGA. Three sites were used for the insertion of either UGA or UGC (encoding cysteine; Fig. 5A). One of these was the original PHGPx site used in the earlier experiments (Fig. 2A), although the other two were excised from the SelP gene (nucleotides 934-990) and fused on to the 3' end of the PHGPx gene segment. It was observed that the incorporation level differed for the respective sites used in this experiment (I00, 0I0, and 00I, Fig. 5B). The results described earlier in this paper indicate that this variation can be explained at least partially in terms of differences in the environment of each UGA. For example, the distinct identities of the final codon pairs immediately 5' of each UGA may contribute to the differences in incorporation efficiency. This phenomenon was not investigated further because it is not of immediate relevance to the main objective of the multiple UGA experiments.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of multiple UGAs on selenocysteine incorporation. A, a segment of the selP gene (GenBankTM accession number Z11793; nucleotides 934-990), containing two UGA codons, was inserted into the BamHI site of the reporter construct (Fig. 2B). This diagram indicates the relative positions of the PHGPx UGA codon and the two selP UGA codons. The synthetic copy of the selenoprotein P gene segment inserted was as follows: 5'-GA TCT TGA TGC TGC CAT TGT CGA CAT CTG ATA TTT GAA AAA ACA GGG TCT GCA ATC ACC TGA TTA G-3'. The selenocysteine incorporation sites are underlined or boxed. B, selenocysteine incorporation at multiple sites. Reporter plasmids pT18-pT32 (Table II) were used for transfection of BHK-21 cells, and SECIS-dependent stop codon suppression efficiencies were determined. TGA or TGC codons are indicated by 1 or 0 on the x axis. C, Western blotting indicates the relative amounts of beta -gal::Luc fusion protein synthesized under the direction of constructs bearing one or two UGA codons. Extracts were prepared from transiently transfected BHK-21 cells, separated on a 6% SDS/polyarylamide gel, and proteins were blotted onto a polyvinylidene difluoride membrane. The beta -gal-Luc fusion protein (approximately 178 kDa) was detected using anti-luciferase antibody. The control cells were not transfected. The presence of TGA or TGC at each position is indicated by a 1 or a 0, respectively. The SECIS-mediated incorporation accounts for a large proportion of the fusion protein synthesized in the presence of one or two UGAs.

More strikingly, combining the individual UGAs in different permutations in a single reading frame resulted in very marked reductions in SECIS-dependent suppression of termination (Fig. 5B). The combination of UGAs at all three sites resulted in particularly low yields of luciferase activity. This effect was also evident in the amounts of beta - galactosidase::luciferase protein detectable in cell extracts by means of Western blotting (Fig. 5C). The sharp reduction in the abundance of the full-length protein upon the introduction of more than one UGA into the reporter system is clearly apparent. Two further types of result indicate that this is due to alterations in the overall efficiency of selenocysteine incorporation rather than changes in the fate of the mRNA. First, we found that the levels of beta -galactosidase encoded by these constructs were not reduced in response to the introduction of additional UGA codons (data not shown). Had there been general destabilization of the fusion mRNAs, we would have expected an associated loss of measurable beta -galactosidase activity. Second, quantitative reverse transcriptase-PCR experiments also indicated that these changes were not attributable to variations in the abundance of the mRNAs encoded by the respective constructs (data not shown). Differences in the abundance of the encoded mRNAs were estimated to be no greater than 2-fold with respect to the non-UGA-carrying control.

One potential role of SECIS elements, at least theoretically, could be to suppress translation termination directly. However, the Western blotting data (for example see Fig. 5C) clearly showed that the yield of fusion protein was greatly reduced when multiple UGAs were present in the reporter mRNA. Given that expression through the lacZ domain was maintained (see above), this indicates that the primary non-SECIS-dependent event at the UGA codons was termination, as opposed to amino acid misincorporation.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have investigated a range of parameters that could influence the efficiency of selenocysteine incorporation at single or multiple sites in selenoprotein genes. A number of factors are capable of attenuating the incorporation rate, but not sufficiently to suggest that the normal cellular level of selenocysteine incorporation is equivalent to 100% efficiency. Indeed, the data reported here, combined with the fact that there is considerable variation in the efficiencies supported by different SECIS elements (3, 24), indicate that termination occurs in parallel with selenocysteine incorporation at the UGA sites in selenoprotein mRNAs. There may be considerable variation in the relative rates of termination and selenocysteine incorporation at different UGA codons. It is striking that using the natural sequence contexts from selenoprotein genes in the expression constructs described here, we have obtained higher absolute levels of selenocysteine incorporation compared with the results obtained previously using short, self-designed UGA-containing sequences (24). However, the incorporation efficiencies obtained with transfected cells may not be representative of the maximum attainable values. Indeed, the incorporation efficiencies for natural genomic selenoprotein genes may be higher.

An alternative model for the mode of action of the SECIS element is that it not only promotes selenocysteine incorporation but also directly suppresses translation termination at UGA codons. However, unless there was a large increase in the mistranslation rate at the UGA site, any suppression on termination rate would have to feed back on the overall rate of protein synthesis. Because neither of these phenomena were observed (Fig. 5), we conclude that this model does not provide an adequate explanation of the results.

The competitive relationship between termination and selenocysteine incorporation can be modulated by a number of manipulations in the sequence region containing the UGA. Most strikingly, changes in the penultimate codons that precede the UGA can have a dramatic effect on the ability of the system to incorporate selenocysteine. However, we have found that termination-promoting codons, and thus the encoded amino acids, are evidently avoided among selenoprotein genes. The other cis-acting elements in the neighborhood of the UGA, the fourth nucleotide and downstream sequence and/or structure, exert a comparatively minor influence on selenocysteine incorporation. The observation that increased levels of eRFs have only a minimal observable effect on selenocysteine incorporation is not necessarily inconsistent with the existence of a competitive relationship with termination, because these factors may be close to effective saturation with respect to UGA-directed termination.

The consequences of the competition between termination and selenocysteine incorporation in terms of mRNA stability are difficult to predict. In principle, premature translational termination on an aberrant eukaryotic mRNA can trigger the so-called nonsense-dependent mRNA decay pathway (37). However, selenoprotein mRNAs may constitute a special case, given that the internal stop codon fulfils a key function in the nonaberrant mRNA. So far, it has been found that the stability of glutathione peroxidase 1 mRNA decreases significantly under conditions of selenium limitation, whereas the destabilizing effect of ongoing termination under nonselenium-limited conditions seems to be small (38, 39). In contrast, even under selenium depletion conditions, neither PHGPx mRNA nor gastrointestinal glutathione peroxidase mRNA is destabilized by UGA-directed termination (38, 40). Our finding that the stability of the reporter mRNA used in this work is not markedly affected by changes in the efficiency or position of UGA-dependent termination is therefore consistent with the currently available data about the decay behavior of selenoprotein mRNAs.

We have established that termination and selenocysteine incorporation can occur at varying ratios at the same UGA. How does this affect the course of translation on selenoprotein mRNAs that have multiple internal UGAs? If substoichiometric incorporation occurs at a series of UGAs, the cumulative terminations at the successive sites would result in a significantly reduced yield of full-length selenoprotein. If the incorporation events are entirely independent, this yield would be equivalent to the multiplicative sum of the efficiencies at the individual UGAs. The loss of complete product could theoretically be limited if the incorporation process was processive, because this would mean that once a selenocysteine-incorporating ribosome complex had been established at the first UGA in the gene sequence, subsequent UGAs would all be recoded as selenocysteine.

However, our results are not consistent with the operation of a processive mechanism of selenocysteine incorporation. Even if the efficiencies seen here are not the maximum attainable, this can only have exacerbated (but not generated) the observed result that the combination of two or more UGAs gives rise to additional suppression of the number of polypeptide chains that completes the open reading frame via (multiple) selenocysteine incorporation events. This phenomenon is therefore not attributable to a nonphysiological effect associated with partial saturation of the selenocysteine incorporation machinery and will apply to systems in which the absolute incorporation efficiency per site is greater than that estimated here. Processivity apparently does not provide the key to ensuring that multiple selenocysteine incorporation events occur successfully. The model that emerges from this envisages that termination can occur at any of the internal UGAs and that the interaction of the selenocysteine incorporation machinery with the translating ribosome at one UGA does not lead to enforced incorporation at other UGAs (Fig. 6). This may mean that there can be both assembly and disassembly of the selenocysteine incorporation apparatus on/from the ribosome each time a UGA is recoded. The major distinction to a processive mechanism is that the interaction of the selenocysteine incorporation components with the ribosome does not preprogram its subsequent behavior in a way that commits it to multiple selenocysteine incorporation events.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6.   A nonprocessive model of selenocysteine incorporation. Incorporation of selenocysteine at the first UGA in a multiple UGA mRNA is mediated by a SECIS-binding complex that associates with both the SECIS element and the elongating ribosome, whereby it is capable of suppressing UGA-dependent termination. Selenocysteine is only added substoichiometrically (efficiency, <100%) to the elongating polypeptide chain. For those chains where selenocysteine incorporation has been successful, elongation continues until the second UGA. The SECIS-bound complex may dissociate from the ribosome during this interim phase but then reassociate once the second UGA enters the ribosomal A site. The efficiency of incorporation at the second site is again <100%. This model predicts that the yield obtained with multiple UGAs will be a multiplicative function of the incorporation rates at the individual UGA sites. However, the operation of a mechanism that is partially processive under at least some conditions cannot be ruled out.

We have previously discussed the possibility that processivity might provide a mechanistic explanation for the generation of a selenoprotein such as SelP in adequate amounts (24). However, the current results indicate that the efficiency of selenocysteine incorporation at individual UGA sites is normally high enough to allow an adequate yield of complete SelP protein molecules in the absence of full processivity. At the same time, the proportion of prematurely terminated polypeptide chains generated from an mRNA bearing multiple UGA codons must be high. Given that genes such as SelP are likely to be rare, the resulting energetic wastage is presumably of little consequence in terms of the overall energetics of the cell.

Finally, suboptimal efficiencies of selenocysteine incorporation are not exclusive to eukaryotic systems, because the maximum efficiency of UGA decoding by SelB-GTP-Sec-tRNASec achieved in E. coli so far is estimated to be 7% (41). It is tempting to rationalize such efficiencies purely in terms of the relative absolute abundance of the respective cellular components of the selenocysteine incorporation machineries in the two types of cell. However, as with other cellular systems, it is unlikely that a full understanding of rate control in the selenocysteine incorporation machinery can be achieved until more is known about the supramolecular organization of protein synthesis (41-43).

    ACKNOWLEDGEMENTS

We thank Dr. Marla Berry (Harvard, Boston, MA), Dr. Michel Philippe (CNRS, Rennes, France), and Dr. Alain Krol (Strasbourg, France) for providing expression constructs.

    FOOTNOTES

* This work was supported by the British Biotechnology and Biological Sciences Research Council and the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

|| To whom correspondence should be addressed: Posttranscriptional Control Group, Department of Biomolecular Sciences, UMIST, P.O. Box 88, Manchester M60 IQD, UK. E-mail: J.McCarthy@umist.ac.uk.

    ABBREVIATIONS

The abbreviations used are: UTR, untranslated region; SECIS, selenocysteine insertion sequence; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Böck, A., Forchhammer, K., Heider, J., Leinfelder, W., Sawers, G., Veprek, B., and Zinoni, F. (1991) Mol. Microbiology 5, 515-520[CrossRef][Medline] [Order article via Infotrieve]
2. Böck, A., Forchhammer, K., Heider, J., and Baron, C. (1991) Trends Biochem. Sci. 16, 463-467[CrossRef][Medline] [Order article via Infotrieve]
3. Low, C. C., and Berry, M. J. (1996) Trends Bichem. Sci. 21, 203-208[CrossRef][Medline] [Order article via Infotrieve]
4. Stadtman, T. C. (1996) Annu. Rev. Biochem. 65, 83-100[CrossRef][Medline] [Order article via Infotrieve]
5. Heider, J., Baron, C., and Böck, A. (1992) EMBO J. 11, 3759-3766[Medline] [Order article via Infotrieve]
6. Berry, M. J., Banu, L., Chen, Y., Mandel, S. J., Kieffer, J. D., Harney, J. W., and Larsen, P. R. (1991) Nature 353, 273-276[CrossRef][Medline] [Order article via Infotrieve]
7. Berry, M. J., Banu, L., Harney, J. W., and Larsen, PR. (1993) EMBO J. 12, 3315-3322[Medline] [Order article via Infotrieve]
8. Buettner, C., Harney, J. W., and Larsen, P. R. (1998) J. Biol. Chem. 273, 33374-33378[Abstract/Free Full Text]
9. Walczak, R., Westhof, E., Carbon, P., and Krol, A. (1996) RNA 2, 367-379[Abstract]
10. Walczak, R., Carbon, P., and Krol, A. (1998) RNA 4, 74-84[Abstract]
11. Zinoni, F., Heider, J., and Böck, A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4660-4664[Abstract/Free Full Text]
12. Baron, C., Heider, J., and Böck, A. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4181-4185[Abstract/Free Full Text]
13. Forchhammer, K., and Böck, A. (1991) J. Biol. Chem. 266, 6324-6328[Abstract/Free Full Text]
14. Leinfelder, W., Stadtman, T. C., and Böck, A. (1989) J. Biol. Chem. 264, 9720-9723[Abstract/Free Full Text]
15. Ehrenreich, A., Forchhammer, K., Tormay, P., Veprek, B., and Böck, A. (1992) Eur. J. Biochem. 206, 767-773[Medline] [Order article via Infotrieve]
16. Shen, Q., McQuilkin, P. A., and Newberger, P. E. (1995) J. Biol. Chem. 270, 30448-30452[Abstract/Free Full Text]
17. Shen, Q., Wu, R., Leonard, J. L., and Newberger, P. E. (1998) J. Biol. Chem. 273, 5443-5446[Abstract/Free Full Text]
18. Hubert, N., Walczak, R., Carbon, P., and Krol, A. (1996) Nucleic Acids Res. 24, 464-469[Abstract/Free Full Text]
19. Lesoon, A., Mehta, A., Singh, R., Chisolm, G., and Driscoll, D. M. (1997) Mol. Cell. Biol. 17, 1977-1985[Abstract]
20. Copeland, P. R., and Driscoll, D. M. (1999) J. Biol. Chem. 274, 25447-25454[Abstract/Free Full Text]
21. Yamada, K., Mizutani, T., Ejiri, S., and Totsuka, T. (1994) FEBS Lett. 347, 137-142[CrossRef][Medline] [Order article via Infotrieve]
22. Berry, M. J., Maia, A. L., Kieffer, J. D., Harney, J. W., and Larsen, P. R. (1992) Endocrinology 131, 1848-1852[Abstract]
23. Berry, M. J., Harney, J. W., Ohama, T., and Hatfield, D. L. (1994) Nucleic Acids Res. 22, 3753-3759[Abstract/Free Full Text]
24. Kollmus, H., Flohé, L., and McCarthy, J. E. G. (1996) Nucleic Acids Res. 24, 1195-1201[Abstract/Free Full Text]
25. Hill, K. E., Lloyd, R. S., Yang, J. G., Read, R., and Burk, R. F. (1991) J. Biol. Chem. 266, 10050-10053[Abstract/Free Full Text]
26. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , pp. 1.21-1.105, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
27. Carbon, P., and Krol, A. (1991) EMBO J. 10, 599-606[Medline] [Order article via Infotrieve]
28. Low, S. C., Harney, J. W., and Berry, M. J. (1995) J. Biol. Chem. 270, 21659-21664[Abstract/Free Full Text]
29. Zhouravleva, G., Frolova, L., Le Goff, X., Le Guellec, R., Inge-Vechtomov, S., Kissilev, L., and Philippe, M (1995) EMBO J. 14, 4065-4072[Medline] [Order article via Infotrieve]
30. Tassan, J. P., Le Guellec, K., Kress, M., Faure, M., Camonis, J., Jacquet, M., and Philippe, M. (1993) Mol. Cell. Biol. 13, 2815-2821[Abstract/Free Full Text]
31. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
32. Towbin, H., Staehelin, T., and Gordon, G. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract/Free Full Text]
33. Brigelius-Flohé, R., Aumann, K.-D., Blöcker, H., Gross, G., Kiess, M., Klöppel, K.-D., Maiorino, M., Rovri, A., Schuckelt, R., Ursini, F., Wingender, E., and Flohé, L. (1994) J. Biol. Chem. 269, 7342-7348[Abstract/Free Full Text]
34. McCaughan, K. K., Brown, C. M., Dalphin, M. E., Berry, M. J., and Tate, W. P. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5431-5435[Abstract/Free Full Text]
35. Bjornsson, A., Mottagui-Tabar, S., and Isaksson, L. A. (1996) EMBO J. 15, 1696-1704[Medline] [Order article via Infotrieve]
36. Moustafa, M. E., El-Saadan, M. A., Kandeel, K. M., Mansur, D. E., Lee, B. J., Hatfield, D. L., and Diamond, A. M. (1998) RNA 4, 1436-1443[Abstract]
37. Maquat, L. (1996) Am. J. Hum. Genet. 59, 279-286[Medline] [Order article via Infotrieve]
38. Bermano, G., Arthur, J. R., and Hesketh, J. E. (1996) FEBS Lett. 387, 157-160[CrossRef][Medline] [Order article via Infotrieve]
39. Moriarty, P. M., Reddy, C. C., and Maquat, L. (1998) Mol. Cell. Biol. 18, 2932-2939[Abstract/Free Full Text]
40. Wingler, K., Böcher, M., Flohé, L., Kollmus, H., and Brigelius-Flohé, R. (1999) Eur. J. Biochem. 259, 149-157[Medline] [Order article via Infotrieve]
41. Suppmann, S., Persson, B. C., and Böck, A. (1999) EMBO J. 18, 2284-2293[CrossRef][Medline] [Order article via Infotrieve]
42. Negrutskii, B. S., Stapulionis, R., and Deutscher, M. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 964-968[Abstract/Free Full Text]
43. McCarthy, J. E. G. (1998) Microbiol. Mol. Biol. Rev. 62, 1429-1553


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Rederstorff, V. Allamand, P. Guicheney, C. Gartioux, P. Richard, D. Chaigne, A. Krol, and A. Lescure
Ex vivo correction of selenoprotein N deficiency in rigid spine muscular dystrophy caused by a mutation in the selenocysteine codon
Nucleic Acids Res., January 17, 2008; 36(1): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Gupta and P. R. Copeland
Functional Analysis of the Interplay between Translation Termination, Selenocysteine Codon Context, and Selenocysteine Insertion Sequence-binding Protein 2
J. Biol. Chem., December 21, 2007; 282(51): 36797 - 36807.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. T. Nasim and R. C. Trembath
A dual-light reporter system to determine the efficiency of protein-protein interactions in mammalian cells
Nucleic Acids Res., April 11, 2005; 33(7): e66 - e66.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Mehta, C. M. Rebsch, S. A. Kinzy, J. E. Fletcher, and P. R. Copeland
Efficiency of Mammalian Selenocysteine Incorporation
J. Biol. Chem., September 3, 2004; 279(36): 37852 - 37859.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
O. Rengby, L. Johansson, L. A. Carlson, E. Serini, A. Vlamis-Gardikas, P. Karsnas, and E. S. J. Arner
Assessment of Production Conditions for Efficient Use of Escherichia coli in High-Yield Heterologous Recombinant Selenoprotein Synthesis
Appl. Envir. Microbiol., September 1, 2004; 70(9): 5159 - 5167.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
R. R. JAMESON and A. M. DIAMOND
A regulatory role for Sec tRNA[Ser]Sec in selenoprotein synthesis
RNA, July 1, 2004; 10(7): 1142 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Md. T. Nasim, H. M. Chowdhury, and I. C. Eperon
A double reporter assay for detecting changes in the ratio of spliced and unspliced mRNA in mammalian cells
Nucleic Acids Res., October 15, 2002; 30(20): e109 - e109.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. L. Hatfield and V. N. Gladyshev
How Selenium Has Altered Our Understanding of the Genetic Code
Mol. Cell. Biol., June 1, 2002; 22(11): 3565 - 3576.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ma, K. E. Hill, R. M. Caprioli, and R. F. Burk
Mass Spectrometric Characterization of Full-length Rat Selenoprotein P and Three Isoforms Shortened at the C Terminus. EVIDENCE THAT THREE UGA CODONS IN THE mRNA OPEN READING FRAME HAVE ALTERNATIVE FUNCTIONS OF SPECIFYING SELENOCYSTEINE INSERTION OR TRANSLATION TERMINATION
J. Biol. Chem., April 5, 2002; 277(15): 12749 - 12754.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow